Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Roka Bioscience Inc (ROKA)

Roka Bioscience Inc (ROKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Roka Bioscience Inc 20 INDEPENDENCE BOULEVARD WARREN NJ 07059 USA

www.rokabio.com P: 908-605-4700

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Roka Bioscience, Inc. is a molecular diagnostics company. It is focused on developing and commercializing advanced testing solutions for the food safety testing market. Roka provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin-producing E. coli, and Listeria monocytogenes, as well as related consumable supplies. Roka Bioscience, Inc. is headquartered in Warren, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 3,257
Shares Outstanding, K 5,010
% of Insider Shareholders 29.20%
% of Institutional Shareholders 48.14%

Financials:

Annual Sales, $ 7,240 K
Annual Net Income, $ -30,790 K
Last Quarter Sales, $ 1,910 K
Last Quarter Net Income, $ 60 K

Growth:

1-Year Return -84.85%
3-Year Return -98.51%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/08/18
Earnings Per Share ttm -7.76
EPS Growth vs. Prev Qtr -4.07%
EPS Growth vs. Prev Year 76.25%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/12/16

ROKA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -121.16%
Return-on-Assets % -68.52%
Profit Margin % -425.28%
Debt/Equity 0.00
Price/Sales 0.46
Price/Cash Flow N/A
Price/Book 0.26
Book Value/Share 2.49
Interest Coverage 0.00
60-Month Beta 2.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.